ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 20 filers reported holding ENZYMOTEC LTD in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $207,000 | -87.0% | 17,913 | -90.9% | 0.00% | -85.7% |
| Q2 2017 | $1,592,000 | -23.8% | 196,306 | -17.2% | 0.01% | -30.0% |
| Q1 2017 | $2,088,000 | +38.6% | 237,184 | +3.2% | 0.01% | +42.9% |
| Q4 2016 | $1,506,000 | -5.5% | 229,862 | +0.7% | 0.01% | -12.5% |
| Q3 2016 | $1,594,000 | -23.2% | 228,304 | -8.1% | 0.01% | -27.3% |
| Q2 2016 | $2,076,000 | +36.3% | 248,317 | +47.2% | 0.01% | +37.5% |
| Q1 2016 | $1,523,000 | +31.6% | 168,738 | +42.9% | 0.01% | +33.3% |
| Q4 2015 | $1,157,000 | +149.4% | 118,072 | +129.8% | 0.01% | +100.0% |
| Q3 2015 | $464,000 | +714.0% | 51,370 | +647.4% | 0.00% | – |
| Q2 2015 | $57,000 | +16.3% | 6,873 | 0.0% | 0.00% | – |
| Q1 2015 | $49,000 | -7.5% | 6,873 | 0.0% | 0.00% | – |
| Q4 2014 | $53,000 | +15.2% | 6,873 | 0.0% | 0.00% | – |
| Q3 2014 | $46,000 | -77.0% | 6,873 | -53.3% | 0.00% | -100.0% |
| Q2 2014 | $200,000 | -86.1% | 14,713 | -77.6% | 0.00% | -87.5% |
| Q1 2014 | $1,442,000 | +111.4% | 65,575 | +159.5% | 0.01% | +100.0% |
| Q4 2013 | $682,000 | – | 25,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIGER MANAGEMENT L.L.C. | 1,143,145 | $10,323,000 | 2.59% |
| Visium Asset Management, LP | 2,200,000 | $19,866,000 | 0.34% |
| Paulson & Co. | 4,224,139 | $38,144,000 | 0.28% |
| ALGERT GLOBAL LLC | 20,988 | $190,000 | 0.07% |
| MENTA CAPITAL LLC | 43,126 | $389,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 61,844 | $558,000 | 0.04% |
| Acrospire Investment Management LLC | 2,785 | $25,000 | 0.02% |
| ICON ADVISERS INC/CO | 16,800 | $152,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 168,738 | $1,523,000 | 0.01% |
| Renaissance Technologies | 181,000 | $1,634,000 | 0.00% |